Serveur d'exploration sur le peuplier - Exploration (Accueil)

Index « Keywords » - entrée « Treatment Outcome (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Transposases (genetics) < Treatment Outcome (MeSH) < Trees (MeSH)  Facettes :

List of bibliographic references indexed by Treatment Outcome (MeSH)

Number of relevant bibliographic references: 65.
[0-50] [0 - 20][0 - 50][50-64][50-70]
Ident.Authors (with country if any)Title
000418 (2020) Bhasker Amatya [Australie] ; Fary Khan ; Imogen Windle ; Matthew Lowe ; Mary P. GaleaEvaluation of a technology-assisted enriched environmental activities programme for upper limb function: A randomized controlled trial.
000484 (2020) Andrew M. Chanen [Australie] ; Katie Nicol [Australie] ; Jennifer K. Betts [Australie] ; Katherine N. Thompson [Australie]Diagnosis and Treatment of Borderline Personality Disorder in Young People.
000620 (2019) Melissa Bardell-Williams [Australie] ; Scott Eaton [Australie] ; Linglee Downey [Australie] ; Meghan Bowtell [Australie] ; Kristen Thien [Australie] ; Aswin Ratheesh [Australie] ; Eoin Killackey [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie]Rates, determinants and outcomes associated with the use of community treatment orders in young people experiencing first episode psychosis.
000621 (2019) Ashley M. Hopkins [Australie] ; Ganessan Kichenadasse [Australie] ; Ross A. Mckinnon [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie]Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors.
000671 (2019) Da Jung Kim [Australie] ; Ellie Brown [Australie] ; Siobhan Reynolds [Australie] ; Hellen Geros [Australie] ; Holly Sizer [Australie] ; Rachel Tindall [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie]The rates and determinants of disengagement and subsequent re-engagement in young people with first-episode psychosis.
000700 (2019) Melissa Pyle [Royaume-Uni] ; Matthew R. Broome [Royaume-Uni] ; Emmeline Joyce [Royaume-Uni] ; Graeme Maclennan [Royaume-Uni] ; John Norrie [Royaume-Uni] ; Daniel Freeman [Royaume-Uni] ; David Fowler [Royaume-Uni] ; Peter M. Haddad [Royaume-Uni, Qatar] ; David Shiers [Royaume-Uni] ; Chris Hollis [Royaume-Uni] ; Jo Smith [Royaume-Uni] ; Ashley Liew [Royaume-Uni] ; Rory E. Byrne [Royaume-Uni] ; Paul French [Royaume-Uni] ; Sarah Peters [Royaume-Uni] ; Jemma Hudson [Royaume-Uni] ; Linda Davies [Royaume-Uni] ; Richard Emsley [Royaume-Uni] ; Alison Yung [Royaume-Uni, Australie] ; Max Birchwood [Royaume-Uni] ; Eleanor Longden [Royaume-Uni] ; Anthony P. Morrison [Royaume-Uni]Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
000734 (2019) David Sands Johnson [Royaume-Uni] ; Philip Gartside Turner [Royaume-Uni]Replacement for patellofemoral arthritis.
000A05 (2019) Karl Andriessen [Australie] ; Karolina Krysinska [Australie] ; Nicole T M. Hill [Australie] ; Lennart Reifels [Australie] ; Jo Robinson [Australie] ; Nicola Reavley [Australie] ; Jane Pirkis [Australie]Effectiveness of interventions for people bereaved through suicide: a systematic review of controlled studies of grief, psychosocial and suicide-related outcomes.
000B19 (2019) Yu Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine] ; Jin Li [République populaire de Chine] ; Ying-Ying Huang [République populaire de Chine] ; Yi Li [République populaire de Chine] ; Jing Lin [République populaire de Chine] ; Li-Zhu Chen [République populaire de Chine] ; Jian-Ping Lu [République populaire de Chine] ; Yu-Qi Wang [République populaire de Chine] ; Chang-Xi Wang [République populaire de Chine] ; Leong Kin Pan [République populaire de Chine] ; Xue-Feng Xia [République populaire de Chine] ; Xin Yi [République populaire de Chine] ; Chuan-Ben Chen [République populaire de Chine] ; Xiong-Wei Zheng [République populaire de Chine] ; Zeng-Qing Guo [République populaire de Chine] ; Jian-Ji Pan [République populaire de Chine]Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
000B63 (2019) Michael Berk [Australie] ; Alyna Turner [Australie] ; Gin S. Malhi [Australie] ; Chee H. Ng [Australie] ; Susan M. Cotton [Australie] ; Seetal Dodd [Australie] ; Yuval Samuni [Australie] ; Michelle Tanious [Australie] ; Claire Mcaulay [Australie] ; Nathan Dowling [Australie] ; Jerome Sarris [Australie] ; Lauren Owen [Royaume-Uni] ; Astrid Waterdrinker [Australie] ; Deidre Smith [Australie] ; Olivia M. Dean [Australie]A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
000C46 (2018) Evan Landau [États-Unis] ; Shalom Kalnicki [États-Unis]The Evolving Role of Radiation in Pancreatic Cancer.
000C71 (2018) Kelly A. Allott [Australie] ; Hok Pan Yuen [Australie] ; Cali F. Bartholomeusz [Australie] ; Marta Rapado-Castro [Espagne] ; Christina Phassouliotis [Australie] ; Felicity Butselaar [Australie] ; Stephen J. Wood [Royaume-Uni] ; Tina-Marie Proffitt [Australie] ; Greg Savage [Australie] ; Lisa J. Phillips [Australie] ; Sarah Bendall [Australie] ; Connie Markulev [Australie] ; Renate L E P. Reniers [Royaume-Uni] ; Christos Pantelis [Australie] ; Lara Baldwin [Australie] ; Patrick D. Mcgorry [Australie] ; Belinda Garner [Australie]Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.
000D22 (2018) Raja B. Khan [États-Unis] ; Thomas E. Merchant [États-Unis] ; Zsila S. Sadighi [États-Unis] ; Mercedes S. Bello [États-Unis] ; Zhaohua Lu [États-Unis] ; April Sykes [États-Unis] ; Merrill S. Wise [États-Unis] ; Valerie M. Crabtree [États-Unis] ; Jennifer Zabrowski [États-Unis] ; Andrea Simmons [États-Unis] ; Mary E. Clark [États-Unis] ; Belinda N. Mandrell [États-Unis]Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors.
000D25 (2018) Nilufar Mossaheb [Autriche] ; Miriam R. Sch Fer [Australie] ; Monika Schlögelhofer [Autriche] ; Claudia M. Klier [Autriche] ; Stefan Smesny [Allemagne] ; Patrick D. Mcgorry [Australie] ; Maximus Berger [Australie] ; G Paul Amminger [Australie]Predictors of longer-term outcome in the Vienna omega-3 high-risk study.
000F91 (2018) Kristen Thien [Australie] ; Meghan Bowtell [Australie] ; Scott Eaton [Australie] ; Melissa Bardell-Williams [Australie] ; Linglee Downey [Australie] ; Aswin Ratheesh [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie]Clozapine use in early psychosis.
001086 (2018) Laurent Claret [France] ; Jin Y. Jin [États-Unis] ; Charles Ferté [France] ; Helen Winter [États-Unis] ; Sandhya Girish [États-Unis] ; Mark Stroh [États-Unis] ; Pei He [États-Unis] ; Marcus Ballinger [États-Unis] ; Alan Sandler [États-Unis] ; Amita Joshi [États-Unis] ; Achim Rittmeyer [Allemagne] ; David Gandara [États-Unis] ; Jean-Charles Soria [France] ; René Bruno [France]A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics.
001140 (2017) Chana Weinstock [États-Unis] ; Sean Khozin [États-Unis] ; Daniel Suzman [États-Unis] ; Lijun Zhang [États-Unis] ; Shenghui Tang [États-Unis] ; Sakar Wahby [États-Unis] ; Kirsten B. Goldberg [États-Unis] ; Geoffrey Kim [États-Unis] ; Richard Pazdur [États-Unis]U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
001221 (2017) Philippe Conus [Suisse, Australie] ; Sue Cotton [Australie] ; Benno G. Schimmelmann [Suisse, Allemagne] ; Patrick D. Mcgorry [Australie] ; Martin Lambert [Allemagne]Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.
001242 (2017) S M Cotton [Australie] ; M. Lambert [Allemagne] ; B G Schimmelmann [Suisse] ; K. Filia [Australie] ; V. Rayner [Australie] ; L. Hides [Australie] ; D L Foley [Australie] ; A. Ratheesh [Australie] ; A. Watson [Australie] ; P. Rodger [Australie] ; P D Mcgorry [Australie] ; P. Conus [Suisse]Predictors of functional status at service entry and discharge among young people with first episode psychosis.
001243 (2017) Philippe Conus [Suisse] ; Sue M. Cotton [Australie] ; Shona M. Francey [Australie] ; Brian O'Donoghue [Australie] ; Benno G. Schimmelmann [Suisse] ; Patrick D. Mcgorry [Australie] ; Martin Lambert [Allemagne]Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
001414 (2017) Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Autriche] ; Jana Hesse [Allemagne] ; Monika Schlögelhofer [Autriche] ; Kerstin Langbein [Allemagne] ; Uta-Christina Hipler [Allemagne] ; Maximus Berger [Australie] ; David R. Cotter [Irlande (pays)] ; Heinrich Sauer [Allemagne] ; Patrick D. Mcgorry [Australie] ; G Paul Amminger [Autriche]Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
001472 (2017) Stéphane Morandi [Suisse] ; Philippe Golay [Suisse] ; Martin Lambert [Allemagne] ; Benno G. Schimmelmann [Suisse] ; Patrick D. Mcgorry [Australie] ; Sue M. Cotton [Australie] ; Philippe Conus [Suisse]Community Treatment Order: Identifying the need for more evidence based justification of its use in first episode psychosis patients.
001499 (2017) Edwin K. Luk [Australie] ; Anastasia F. Hutchinson [Australie] ; Mark Tacey [Australie] ; Louis Irving [Australie] ; Fary Khan [Australie]COPD: Health Care Utilisation Patterns with Different Disease Management Interventions.
001629 (2016) Alexandra G. Parker [Australie] ; Sarah E. Hetrick [Australie] ; Anthony F. Jorm [Australie] ; Andrew J. Mackinnon [Australie] ; Patrick D. Mcgorry [Australie] ; Alison R. Yung [Royaume-Uni] ; Faye Scanlan [Australie] ; Jessica Stephens [Australie] ; Shelley Baird [Australie] ; Bridget Moller [Australie] ; Rosemary Purcell [Australie]The effectiveness of simple psychological and physical activity interventions for high prevalence mental health problems in young people: A factorial randomised controlled trial.
001814 (2016) Mary P. Galea [Australie] ; Fary Khan ; Bhasker Amatya ; Alaeldin Elmalik ; Marlena Klaic ; Geoff AbbottImplementation of a technology-assisted programme to intensify upper limb rehabilitation in neurologically impaired participants: A prospective study.
001886 (2016) Robert H. Six [États-Unis] ; Thomas Geurden [Belgique] ; Raj Packianathan [Australie] ; Sally Colgan [Australie] ; William R. Everett [États-Unis] ; Sarah Grace [Irlande (pays)] ; Andrew Hodge [Australie] ; Sean P. Mahabir [États-Unis] ; Melanie R. Myers [États-Unis] ; Nathalie Slootmans [Belgique] ; Kylie Davis [Australie]Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
001993 (2016) M. Alvarez-Jimenez [Australie] ; B. O'Donoghue [Australie] ; A. Thompson [Royaume-Uni] ; J F Gleeson [Australie] ; S. Bendall [Australie] ; C. Gonzalez-Blanch [Espagne] ; E. Killackey [Australie] ; L. Wunderink [Pays-Bas] ; P D Mcgorry [Australie]Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
001995 (2016) Louis Fehrenbacher [États-Unis] ; Alexander Spira [États-Unis] ; Marcus Ballinger [États-Unis] ; Marcin Kowanetz [États-Unis] ; Johan Vansteenkiste [Belgique] ; Julien Mazieres [France] ; Keunchil Park [Corée du Sud] ; David Smith [États-Unis] ; Angel Artal-Cortes [Espagne] ; Conrad Lewanski [Royaume-Uni] ; Fadi Braiteh [États-Unis] ; Daniel Waterkamp [États-Unis] ; Pei He [États-Unis] ; Wei Zou [États-Unis] ; Daniel S. Chen [États-Unis] ; Jing Yi [États-Unis] ; Alan Sandler [États-Unis] ; Achim Rittmeyer [Allemagne]Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
001A11 (2016) Fary Khan [Australie] ; Bhasker Amatya ; Alaeldin Elmalik ; Matthew Lowe ; Louisa Ng ; Isabella Reid ; Mary P. GaleaAn enriched environmental programme during inpatient neuro-rehabilitation: A randomized controlled trial.
001A21 (2016) R. Daglas [Australie] ; S M Cotton [Australie] ; K. Allott [Australie] ; M. Yücel [Australie] ; C A Macneil [Australie] ; M K Hasty [Australie] ; B. Murphy [Australie] ; C. Pantelis [Australie] ; K T Hallam [Australie] ; L P Henry [Australie] ; P. Conus [Suisse] ; A. Ratheesh [Australie] ; L. Kader [Australie] ; M Th Wong [Australie] ; P D Mcgorry [Australie] ; M. Berk [Australie]A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study.
001B22 (2015) Fary Khan ; Bhasker Amatya ; Jurg Kesselring ; Mary GaleaTelerehabilitation for persons with multiple sclerosis.
001B58 (2015) Fary Khan [Australie] ; Bhasker Amatya ; Louisa Ng ; Mary GaleaRehabilitation outcomes in persons with spina bifida: A randomised controlled trial.
001C19 (2015) P. Conus [Australie] ; M. Berk [Australie] ; S M Cotton [Australie] ; L. Kader [Australie] ; C. Macneil [Australie] ; M K Hasty [Australie] ; K. Hallam [Australie] ; M. Lambert [Allemagne] ; B P Murphy [Australie] ; P D Mcgorry [Australie]Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.
001C61 (2015) Edwin K. Luk [Australie] ; Fary Khan [Australie] ; Louis Irving [Australie]Maintaining Gains Following Pulmonary Rehabilitation.
001D11 (2015) Régis Marion-Veyron [Suisse] ; Martin Lambert [Allemagne] ; Sue M. Cotton [Australie] ; Benno G. Schimmelmann [Suisse] ; Bruno Gravier [Suisse] ; Patrick D. Mcgorry [Australie] ; Philippe Conus [Australie]History of offending behavior in first episode psychosis patients: a marker of specific clinical needs and a call for early detection strategies among young offenders.
001E00 (2015) Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Australie] ; Uta-Christina Hipler [Allemagne] ; Christine Milleit [Allemagne] ; Cornelia Wiegand [Allemagne] ; Jana Hesse [Allemagne] ; Claudia M. Klier [Autriche] ; Magdalena Holub [Autriche] ; Ingrid Holzer [Autriche] ; Michael Berk [Australie] ; Patrick D. Mcgorry [Australie] ; Heinrich Sauer [Allemagne] ; G Paul Amminger [Australie]Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.
001F11 (2015) Sue Lauder [Australie] ; Andrea Chester [Australie] ; David Castle [Australie] ; Seetal Dodd [Australie] ; Emma Gliddon [Australie] ; Lesley Berk [Australie] ; James Chamberlain [Australie] ; Britt Klein [Australie] ; Monica Gilbert [Australie] ; David W. Austin ; Michael Berk [Australie]A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder.
001F22 (2015) Peter R. Little [Australie] ; Vickie L. King ; Kylie R. Davis ; Sallie B. Cosgrove ; Michael R. StegemannA blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
001F72 (2014) B J Mckinnon [États-Unis] ; T. Dumon ; R. Hagen ; E. Lesinskas ; R. Mlynski ; M. Profant ; J. Spindel ; J. Van Beek-King ; M. ZernottiVibrant soundbridge in aural atresia: does severity matter?
002017 (2014) Christopher G. Davey [Australie] ; Andrew M. Chanen ; Sue M. Cotton ; Sarah E. Hetrick ; Melissa J. Kerr ; Michael Berk ; Olivia M. Dean ; Kally Yuen ; Mark Phelan ; Aswin Ratheesh ; Miriam R. Sch Fer ; G Paul Amminger ; Alexandra G. Parker ; Danijela Piskulic ; Susy Harrigan ; Andrew J. Mackinnon ; Ben J. Harrison ; Patrick D. McgorryThe addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
002603 (2013) Fary Khan [Australie] ; Bhasker Amatya ; Jürg KesselringLongitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
002695 (2013) Fary Khan [Australie] ; Bhasker AmatyaFactors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.
002752 (2013) Eric J. Sigler [États-Unis] ; John C. Randolph ; Jorge I. Calzada ; Steve CharlesComparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.
002756 (2013) E In Killackey [Australie] ; Mario Alvarez-Jimenez ; Kelly Allott ; Sarah Bendall ; Patrick McgorryCommunity rehabilitation and psychosocial interventions for psychotic disorders in youth.
002970 (2012) Torrance Walker [États-Unis] ; Brian Perkinson ; William M. MihalkoPatellofemoral arthroplasty: the other unicompartmental knee replacement.
002A09 (2012) Craig A. Macneil [Australie] ; Melissa K. Hasty ; Philippe Conus ; Michael BerkIs diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice.
002D40 (2011) Alison R. Yung [Australie] ; Lisa J. Phillips ; Barnaby Nelson ; Shona M. Francey ; Hok Panyuen ; Magenta B. Simmons ; Margaret L. Ross ; Daniel Kelly ; Kathryn Baker ; G Paul Amminger ; Gregor Berger ; Andrew D. Thompson ; Annette Thampi ; Patrick D. McgorryRandomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.
002D69 (2011) G Paul Amminger [Australie] ; Lisa P. Henry ; Susy M. Harrigan ; Meredith G. Harris ; Mario Alvarez-Jimenez ; Helen Herrman ; Henry J. Jackson ; Patrick D. McgorryOutcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study.
003208 (2010) Andrew Court [Australie] ; Claudia Mulder ; Melissa Kerr ; Hok Pan Yuen ; Melissa Boasman ; Sherilyn Goldstone ; Judith Fleming ; Susan Weigall ; Harry Derham ; Chia Huang ; Patrick Mcgorry ; Gregor BergerInvestigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study.
003342 (2010) Sarah Poplar [Royaume-Uni] ; Sarah Allford ; Nicholas RooneyChronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
003736 (2008) K C Schielke [Royaume-Uni] ; A J Hilton ; R. BrownAcquired Brown's syndrome associated with preseptal cellulitis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Treatment Outcome (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Treatment Outcome (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Treatment Outcome (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020